Rapport Therapeutics, Inc. ($RAPP)
Filing Information
| Accession Number | 0001193125-26-429073 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 22, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
35,714
Total Value
$974,277.92
P&L
-8.2% ($79,642.22)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Oct 22, 2026 | Purchase | 35,714 | $27.28 | $974,277.92 | 77,380 | Indirect | By Paul Capital Strategy III Fund LLC | View Details |